Trump’s Pharma Agreements Signal A Shift Toward DTC PricingBy Press Room1 November 2025 President Trump’s recent agreements with Pfizer and AstraZeneca have drawn attention for lowering drug costs and incentivizing domestic manufacturing. Equally…
HHS Is Driving A Paradigm Change Onto The Pharmaceutical IndustryBy Press Room13 October 2025 Last month the Trump Administration announced sweeping changes to the decades old rules that allow pharmaceutical manufacturers to advertise products…
His Business Sells Over 6k Units Daily — at Up to $25k EachBy Press Room23 January 2025 When Amir Loloi immigrated to the U.S. from Iran at age 16 in 1976, he planned to receive an education…